For instance, Song P et al. have shown that asparaginase triggers chronic myelogenous leukemia (CML) to undergo pro-survival autophagy, and a therapeutic strategy combining it with autophagy suppression enhanced its antitumor efficacy [24]. The gene discussed is ASPG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.